Open Nav

Please submit your session questions in advance at

Lyndra Inc

  • Amy Schulman, Lyndra Inc

At Lyndra, we are working to realize a healthier world by transforming the way we take medicine. Our team is developing pills that can last a week or more, freeing patients and caregivers of the burden of daily medications. Expected benefits of our long-acting oral therapies include: better health outcomes and quality of life, reduced side effects, improved drug efficacy, slowed spread of disease, and lower health costs.

  • Date:Tuesday, February 12
  • Time:2:15 PM - 2:30 PM
  • Room:Gramercy
  • Location:7th Floor
  • Session Type:Company Presentation
  • Please submit your session questions in advance:

    Click here.

  • Company Presentation - Presentation Type:Privately Funded Company
  • Submission ID:22541
  • Goal for Presentation:Investment & Partnering Opportunities
  • Company
  • Company HQ City:Watertown
  • Company HQ State:Massachusetts
  • Company HQ Country:United States
  • Total Amount Raised to Date, in All Rounds:$23.5M
  • CEO/Top Company Official:Amy Schulman
  • Year Founded:2015
  • Main Therapeutic Focus:Multiple Therapeutics
  • Lead Product in Development:Alzheimer's Product
  • Development Phase of Primary Product:Phase I
  • Number Of Unlicensed Products (For Which You Are Seeking Partners):4
Amy Schulman
Lyndra Inc